← FDA Drug Approvals (Drugs@FDA)

APIXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO., · Approved 2025-12-19

Drug application

FDA Application #

ANDA218519

Application type

Abbreviated New Drug Application (Generic)

Brand name

APIXABAN

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO.,

First approval

2025-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown